| Literature DB >> 32204059 |
Habib Belaid1, Sakthivel Nagarajan2, Catherine Teyssier3, Carole Barou4, Jonathan Barés5, Sebastien Balme2, Hélène Garay6, Vincent Huon5, David Cornu2, Vincent Cavaillès2, Mikhael Bechelany7.
Abstract
The aim of this work was to develop a bioresorbable, biodegradable and biocompatible synthetic polymer with good mechanical properties for bone tissue engineering applications. Polylactic acid (PLA) scaffolds were generated by 3D printing using the fused deposition modelling method, and reinforced by incorporation of graphene oxide (GO). Morphological analysis by scanning electron microscopy indicated that the scaffold average pore size was between 400 and 500 μm. Topography imaging revealed a rougher surface upon GO incorporation (Sa = 5.8 μm for PLA scaffolds, and of 9.9 μm for PLA scaffolds with 0.2% GO), and contact angle measurements showed a transition from a hydrophobic surface (pure PLA scaffolds) to a hydrophilic surface after GO incorporation. PLA thermomechanical properties were enhanced by GO incorporation, as shown by the 70 °C increase of the degradation peak (thermal gravimetric analysis). However, GO incorporation did not change significantly the melting point assessed by differential scanning calorimetry. Physicochemical analyses by X-ray diffraction and Raman spectroscopy confirmed the filler presence. Tensile testing demonstrated that the mechanical properties were improved upon GO incorporation (30% increase of the Young's modulus with 0.3% GO). Cell viability, attachment, proliferation and differentiation assays using MG-63 osteosarcoma cells showed that PLA/GO scaffolds were biocompatible and that they promoted cell proliferation and mineralization more efficiently than pure PLA scaffolds. In conclusion, this new 3D printed nanocomposite is a promising scaffold with adequate mechanical properties and cytocompatibility which may allow bone formation.Entities:
Keywords: 3D printing; Biocompatibility; Graphene oxide; Nanocomposite; Polylactic acid
Mesh:
Substances:
Year: 2019 PMID: 32204059 DOI: 10.1016/j.msec.2019.110595
Source DB: PubMed Journal: Mater Sci Eng C Mater Biol Appl ISSN: 0928-4931 Impact factor: 7.328